TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21554817

Group type: EXPERIMENTAL
Intervention: Whole-grain wheat (48 g daily for 3 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Refined grain (control)
Number of subjects: 14
Study: 19231157

Group type: EXPERIMENTAL
Intervention: Immediate nephrectomy
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy
Number of subjects: 426
Study: 16580390

Group type: EXPERIMENTAL
Intervention: Gestrinone
Number of subjects: 135

Group type: COMPARATOR
Intervention: Danazol
Number of subjects: 135
Study: 14714091

Group type: EXPERIMENTAL
Intervention: GSTM1, GSTT1, and GSTP1 genotypes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy children
Number of subjects: 0
Study: 10685531

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (100 mg/d) on days 3-7 of the CC-treated cycles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control cycle (no treatment)
Number of subjects: 30
Study: 9692707

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg daily; n = 8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg b.d.; n = 6)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (before treatment; n = 24)
Number of subjects: 24
Study: 8151082

Group type: EXPERIMENTAL
Intervention: Hypoplasia of the corpus callosum
Number of subjects: 445

Group type: COMPARATOR
Intervention: Control group (63 randomly selected individuals)
Number of subjects: 445
Study: 2826067

Group type: EXPERIMENTAL
Intervention: Enalaprilat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline vehicle
Number of subjects: 0
Study: 30392805

Group type: EXPERIMENTAL
Intervention: Limited Bursectomy (LB)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Extensive Bursectomy (EB)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups (LB and EB)
Number of subjects: 75
Study: 27710149

Group type: EXPERIMENTAL
Intervention: Hypoxia (2000m above sea level)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normoxia (sea level)
Number of subjects: 12
Study: 25760389

Group type: EXPERIMENTAL
Intervention: 5% glycolic plant extract applied externally (gel cream) for 21 days
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (no active treatment)
Number of subjects: 8
Study: 23803886

Group type: EXPERIMENTAL
Intervention: β‐carotene supplementation
Number of subjects: 200
Study: 20099236

Group type: EXPERIMENTAL
Intervention: Fixed combination latanoprost-timolol (n = 170)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Latanoprost monotherapy (n = 165)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Timolol monotherapy (n = 165)
Number of subjects: 500
Study: 18402906

Group type: EXPERIMENTAL
Intervention: SR123781A 0.25 mg
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: SR123781A 0.5 mg
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: SR123781A 1.0 mg
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: SR123781A 2.0 mg
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: SR123781A 4.0 mg
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg (calibrator arm)
Number of subjects: 1023
Study: 16376979

Group type: EXPERIMENTAL
Intervention: Pilates classes for 4 weeks, 1 hour per day, 5 days a week.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no Pilates intervention).
Number of subjects: 30
Study: 12386357

Group type: EXPERIMENTAL
Intervention: Intratubal methotrexate 1 mg/kg
Number of subjects: 65

Group type: COMPARATOR
Intervention: Linear salpingotomy (Control)
Number of subjects: 65
Study: 10458218

Group type: EXPERIMENTAL
Intervention: Vorozole (VOR) 2.5 mg once daily
Number of subjects: 452

Group type: COMPARATOR
Intervention: Megestrol acetate (MA) 40 mg four times per day
Number of subjects: 452
Study: 7605361

Group type: EXPERIMENTAL
Intervention: Kwai garlic powder tablets 300 mg three times daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 28
Study: 2163851

Group type: EXPERIMENTAL
Intervention: Sinorphan
Number of subjects: 9

Group type: COMPARATOR
Intervention: Retorphan
Number of subjects: 9
Study: 350002

Group type: EXPERIMENTAL
Intervention: Cotrel traction and exercises
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise programme
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cotrel traction
Number of subjects: 10
Study: 7119301

Group type: EXPERIMENTAL
Intervention: Budesonide 400 micrograms/day, q.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms/day, q.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Budesonide 1600 micrograms/day, q.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Budesonide 400 micrograms/day, b.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms/day, b.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Budesonide 1600 micrograms/day, b.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Budesonide (various doses), morning dosing
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Budesonide (various doses), reduced dose frequency
Number of subjects: 34
Study: 30877269

Group type: EXPERIMENTAL
Intervention: tDCS to the DLPFC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 20
Study: 29946175

Group type: EXPERIMENTAL
Intervention: Ledipasvir-sofosbuvir regimen (8-12 weeks)
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Teleconsultation program for follow-up
Number of subjects: 847
Study: 27060731

Group type: EXPERIMENTAL
Intervention: Integrated theory-based intervention (outcome mental simulation: present vs. absent; action planning: standard vs. reasoning vs. absent)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Intervention manipulations (either of the intervention manipulation or combination)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Control group (participants who did not receive intervention manipulations)
Number of subjects: 316
Study: 25526462

Group type: EXPERIMENTAL
Intervention: Deep needling
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Shallow needling
Number of subjects: 475

Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 475
Study: 22406033

Group type: EXPERIMENTAL
Intervention: Bright white light (∼4200 lux) for 30 min every day
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Dim red light (∼90 lux) for 30 min every day
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Sleep hygiene therapy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Phototherapy regimen
Number of subjects: 54

Group type: COMPARATOR
Intervention: Actigraphy measures
Number of subjects: 54
Study: 19170451

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual community services (UCS)
Number of subjects: 48
Study: 17947598

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (0.2 g/kg/d of nitrogen and 30 nonprotein kcal/kg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard hospital oral diet (control group)
Number of subjects: 20
Study: 15939923

Group type: COMPARATOR
Intervention: Fluorouracil (FU) 2.6 g/m(2) and folinic acid (FA) 500 mg/m(2) weekly for 6 weeks followed by a 2-week rest (AIO arm, n = 216)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Fluorouracil (FU) 2.3 or 2.0 g/m(2) preceded by irinotecan 80 mg/m(2) administered over 30 minutes weekly for 6 weeks followed by a 2-week rest (experimental group, n = 214)
Number of subjects: 430
Study: 12439209

Group type: EXPERIMENTAL
Intervention: Single-dose nevirapine (NVP)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Short-course zidovudine (AZT)
Number of subjects: 86
Study: 10456819

Group type: EXPERIMENTAL
Intervention: Single-injection paravertebral block at the level of T4
Number of subjects: 86

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 86
Study: 7727812

Group type: EXPERIMENTAL
Intervention: Novacor N120 Left Ventricular Assist System
Number of subjects: 0
Study: 2357777

Group type: EXPERIMENTAL
Intervention: Intravenous potassium chloride (Group I, 44 patients)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Intravenous saline (Group II, 48 patients)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Oral potassium chloride capsules (Group III, 50 patients)
Number of subjects: 189

Group type: COMPARATOR
Intervention: No additional treatment (Group IV, 47 patients)
Number of subjects: 189
Study: 26518

Group type: EXPERIMENTAL
Intervention: Proglumide (1200 mg per day for 28 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cimetidine (1200 mg per day for 28 days)
Number of subjects: 30
Study: 31568387

Group type: EXPERIMENTAL
Intervention: Plantar flexor strengthening associated with conventional physical therapy treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group treatment (gait training, triceps surae muscle stretching, anterior tibial muscle strengthening, and motor sensory training)
Number of subjects: 30
Study: 28767002

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention
Number of subjects: 535

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 535
Study: 27044796

Group type: COMPARATOR
Intervention: Gentamicin cream
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Alternating gentamicin/mupirocin regimen
Number of subjects: 146
Study: 25061882

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 212

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 212
Study: 22283635

Group type: EXPERIMENTAL
Intervention: LFD
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: LFD&PRE
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: CRD
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: CRD&PRE
Number of subjects: 42
Study: 19019257

Group type: EXPERIMENTAL
Intervention: Plant stanol or sterol ester (2 g)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control spread
Number of subjects: 282
Study: 17682990

Group type: EXPERIMENTAL
Intervention: Zinc nasal gel
Number of subjects: 14

Group type: COMPARATOR
Intervention: Zinc lozenges or nasal spray
Number of subjects: 14
Study: 16405839

Group type: EXPERIMENTAL
Intervention: Cytokines absorption using sulfonated polyacrylonitrile hemofilter (AN69)
Number of subjects: 30
Study: 12021824

Group type: EXPERIMENTAL
Intervention: 125 mg caffeine
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 325 mg caffeine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo-informed instructions
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo-uninformed instructions
Number of subjects: 52
Study: 10193919

Group type: EXPERIMENTAL
Intervention: Allergic Rhinitis (AR)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vasomotor Rhinitis (VMR)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control Group (Healthy Nonallergic Women)
Number of subjects: 45
Study: 8533175

Group type: EXPERIMENTAL
Intervention: Minimal exercise (twice weekly for three months)
Number of subjects: 20
Study: 2080308

Group type: EXPERIMENTAL
Intervention: UDPG (400 mg/im/die for 30 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: UDPG
Number of subjects: 40
Study: 374446

Group type: EXPERIMENTAL
Intervention: Methylphenidate (Ritalin)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31751776

Group type: EXPERIMENTAL
Intervention: Telemedicine care model (CoYoT1 Clinic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-person care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-centered care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 30590857

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg) plus hyoscine butylbromide (20 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29268677

Group type: EXPERIMENTAL
Intervention: Arabic numeral anchor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal format anchor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Numeric information presentation
Number of subjects: 0
Study: 26446726

Group type: EXPERIMENTAL
Intervention: Home-based Parent-child Interaction Therapy (PCIT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard pediatric primary care
Number of subjects: 60
Study: 23875989

Group type: EXPERIMENTAL
Intervention: Proactive retention strategies including obtaining extensive contact information, building relationships with case managers and social workers, contacting jails and prisons, text messaging, e-mailing, messaging via social networking sites, identifying appointments via electronic medical record, and field outreach to treatment facilities, residences, and parks.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Proactive retention strategies
Number of subjects: 100
Study: 22765333

Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention
Number of subjects: 115

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 115
Study: 19228214

Group type: EXPERIMENTAL
Intervention: Lidocaine inferior alveolar nerve block (IANB) with supplementary articaine buccal infiltration (2 mL of articaine 4% with epinephrine 1:100,000)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Lidocaine inferior alveolar nerve block (IANB) alone
Number of subjects: 36

Group type: COMPARATOR
Intervention: Buccal infiltration with articaine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dummy buccal injection
Number of subjects: 36
Study: 17255371

Group type: EXPERIMENTAL
Intervention: Aprepitant (NK1 antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15371667

Group type: COMPARATOR
Intervention: Cyclosporine (CsA) once a day (OD group)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) twice a day (BD group)
Number of subjects: 54
Study: 11436232

Group type: EXPERIMENTAL
Intervention: Chalk-based antimicrobial dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 0
Study: 9620812

Group type: EXPERIMENTAL
Intervention: Furlow double-reversing Z-plasty palatoplasty
Number of subjects: 608

Group type: COMPARATOR
Intervention: von Langenbeck procedure with intravelar velarplasty
Number of subjects: 608
Study: 7533998

Group type: EXPERIMENTAL
Intervention: Costimulatory stromal receptors identified in thymuses and TETs
Number of subjects: 0
Study: 3065101

Group type: EXPERIMENTAL
Intervention: Bumetanide (group A, n = 13)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Spironolactone (group B, n = 12)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Combination of bumetanide and spironolactone (group C, n = 12)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 37
Study: 28939500

Group type: EXPERIMENTAL
Intervention: AV re-education via smartphone
Number of subjects: 283

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: 4-L PEG
Number of subjects: 283
Study: 26833454

Group type: EXPERIMENTAL
Intervention: Combination of diacetyl boldine (DAB) serum at night and DAB/TGF‐β1 biomimetic oligopeptide‐68/sunscreen cream in the morning and at noon
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% and 4% hydroquinone cream (HQ)
Number of subjects: 40
Study: 24655469

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion protocol with a trigger of hemoglobin ≤ 6 g/dL; transfusion acceptable for hemoglobin 6-8 g/dL and only with evidence of end-organ ischemia for hemoglobin 8-10 g/dL.
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Transfusion for hemoglobin 6-8 g/dL
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Transfusion for hemoglobin 8-10 g/dL with evidence for end-organ ischemia
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Avoidance of allogeneic transfusion
Number of subjects: 409
Study: 23091107

Group type: EXPERIMENTAL
Intervention: Belief-type query
Number of subjects: 171

Group type: COMPARATOR
Intervention: Combination query
Number of subjects: 171

Group type: COMPARATOR
Intervention: Frequency-type query
Number of subjects: 171
Study: 20544311

Group type: EXPERIMENTAL
Intervention: WATCHMAN device for left atrial appendage closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical exclusion of the left atrial appendage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Novel pharmacologic agents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study: 18278183

Group type: EXPERIMENTAL
Intervention: Raloxifene therapy
Number of subjects: 24523
Study: 15811089

Group type: EXPERIMENTAL
Intervention: pioglitazone 15 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: pioglitazone 30 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study: 12220418

Group type: EXPERIMENTAL
Intervention: Multimodal therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 10598598

Group type: EXPERIMENTAL
Intervention: Dobutamine (6 microg x kg(‐1)min(‐1))
Number of subjects: 17
Study: 8566605

Group type: EXPERIMENTAL
Intervention: Perfusion with camostate (synthetic protease inhibitor)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Perfusion with protein
Number of subjects: 9

Group type: COMPARATOR
Intervention: Perfusion with camostate with protein
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Perfusion with amino acids
Number of subjects: 9

Group type: COMPARATOR
Intervention: Perfusion with camostate with amino acids
Number of subjects: 9
Study: 8877232

Group type: EXPERIMENTAL
Intervention: Pre-operative amoxycillin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pre-operative cefaclor
Number of subjects: 70

Group type: COMPARATOR
Intervention: No antibiotic (control)
Number of subjects: 70
Study: 2878274

Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 24
Study: 28984089

Group type: EXPERIMENTAL
Intervention: Spritztube (ST)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Fastrach laryngeal mask airway (FT‐LMA)
Number of subjects: 47
Study: 26486704

Group type: EXPERIMENTAL
Intervention: DEC 6 mg/kg + ALB 400 mg + IVM 200 μg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: DEC 6 mg/kg + ALB 400 mg
Number of subjects: 24
Study: 26595748

Group type: EXPERIMENTAL
Intervention: Omit NRTIs
Number of subjects: 360

Group type: COMPARATOR
Intervention: Add NRTIs
Number of subjects: 360
Study: 22747197

Group type: EXPERIMENTAL
Intervention: Cycle ergometry training (30-min once weekly for 6 weeks)
Number of subjects: 23
Study: 22046325

Group type: EXPERIMENTAL
Intervention: Education + Pedometer
Number of subjects: 43

Group type: COMPARATOR
Intervention: Education only
Number of subjects: 43
Study: 18989711

Group type: EXPERIMENTAL
Intervention: Intermittent dexamethasone (DEXA)
Number of subjects: 16
Study: 17163477

Group type: EXPERIMENTAL
Intervention: VelaSmooth
Number of subjects: 20

Group type: COMPARATOR
Intervention: TriActive
Number of subjects: 20
Study: 12971029

Group type: EXPERIMENTAL
Intervention: 40 mg valdecoxib
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 80 mg valdecoxib
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 120 mg valdecoxib
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 10849221

Group type: EXPERIMENTAL
Intervention: Motor skills of blind children
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group of sighted children
Number of subjects: 40
Study: 7720361

Group type: EXPERIMENTAL
Intervention: Evidence including mechanism information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conflicting evidence matching in covariation values
Number of subjects: 0
Study: 2166308

Group type: EXPERIMENTAL
Intervention: 0.025 mmol Gd-DTPA/kg body weight
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 0.05 mmol Gd-DTPA/kg body weight
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 0.1 mmol Gd-DTPA/kg body weight
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 0.2 mmol Gd-DTPA/kg body weight (further increase in group 3)
Number of subjects: 33
Study: 7325201

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry without fluorescein (Ophthetic only)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Goldmann applanation tonometry with fluorescein (Fluress)
Number of subjects: 100
Study: 30856101

Group type: EXPERIMENTAL
Intervention: OPEN procedures
Number of subjects: 35

Group type: COMPARATOR
Intervention: MIS procedures
Number of subjects: 35
Study: 28079569

Group type: EXPERIMENTAL
Intervention: Standing Cough Stress Test (CST)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Supine Cough Stress Test (CST)
Number of subjects: 60
Study: 26200978

Group type: EXPERIMENTAL
Intervention: Nodal-irradiation group
Number of subjects: 4004

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4004
Study: 23816325

Group type: EXPERIMENTAL
Intervention: Quality-controlled CPR using a monitor-defibrillator with a quality analysis feature
Number of subjects: 187

Group type: COMPARATOR
Intervention: Not applicable (control group not explicitly mentioned)
Number of subjects: 187
Study: 21661426

Group type: EXPERIMENTAL
Intervention: Tacrolimus (Tac) in double therapy (plus steroids)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cyclosporine microemulsion (CyA‐me) in triple therapy (plus steroids and azathioprine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Conversion to Tac from CyA‐me
Number of subjects: 100
Study: 19748641

Group type: EXPERIMENTAL
Intervention: Ambulatory physical exercise program (aerobic and anaerobic)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional information about diet and exercise
Number of subjects: 106
Study: 16529046

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0
Study: 14693085

Group type: EXPERIMENTAL
Intervention: Ampicillin and cloxacillin (group 1)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Erythromycin and genticin (group 2)
Number of subjects: 61

Group type: COMPARATOR
Intervention: No systemic chemo prophylaxis (control group)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Comparison of treatment groups vs control
Number of subjects: 61